The Molecular Development section develops and validates high-quality real-time PCR assays, allowing the VDL to be a leader in detecting and diagnosing emerging and existing diseases. Additionally, the Molecular Development section improves existing assays by making them faster, more sensitive, and more accurate. This gives our clients the confidence to make fact-based decisions when time is critical.
The Molecular Development section also provides next-generation sequencing (NGS) services with in-house expertise on nucleic acid extraction, library preparation, and bioinformatics for analysis and interpretation of results. Using the latest techniques and technologies available, genomic data can be obtained from a wide variety of sample types.